[1] Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci, 2012, 25:251-6. http://www.besjournal.com/Articles/Archive/archive/No3/201207/P020120712460143315034.pdf
[2] Xu J, Yang Y. Traditional Chinese medicine in the Chinese health care system. Health Policy, 2009, 90:133-9. doi:  10.1016/j.healthpol.2008.09.003
[3] Li W, Gu H, Teo KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47, 000 people from china. J Hypertens, 2016, 34:39-46. doi:  10.1097/HJH.0000000000000745
[4] Wei JW, Wang JG, Huang Y, et al. Secondary prevention of ischemic stroke in urban China. Stroke, 2010, 41:967-74. doi:  10.1161/STROKEAHA.109.571463
[5] Angina treatment pattern survey collaborative group. Current status of medical therapy of chronic stable angina pectoris in mainland of China: The second survey. Zhonghua Xin Xue Guan Bing Za Hhi, 2010, 38:1060-4. (In Chinaese) https://www.researchgate.net/publication/296850911_Current_status_of_medical_therapy_of_chronic_stable_angina_pectoris_in_mainland_of_China_the_second_survey
[6] Wu J, Jia LF, Jia JP. Awareness of secondary stroke prevention guidelines among neurologists in china: A cross-sectional online survey. Chin Med J (Engl), 2012, 125:1867-70. http://industry.wanfangdata.com.cn/dl/Detail/Periodical?id=Periodical_zhcmj201211005
[7] Liao JK. Safety and efficacy of statins in Asians. Am J Cardiol, 2007, 99:410-4. doi:  10.1016/j.amjcard.2006.08.051
[8] Jin L. From mainstream to marginal? Trends in the use of Chinese medicine in china from 1991 to 2004. Soc Sci Med, 2010, 71:1063-7. doi:  10.1016/j.socscimed.2010.06.019
[9] Guan X, Liang H, Xue Y, et al. An analysis of China's national essential medicines policy. J Public Health Policy, 2011, 32:305-19. doi:  10.1057/jphp.2011.34